QBTS EQUITY ACTION REMINDER Faruqi & Faruqi, LLP Reminds D-Wave Quantum Investors of Securities Class Action Lawsuit Deadline on December 15, 2026

Faruqi & Faruqi is investigating potential claims against D-Wave Quantum in connection with a federal securities class action filed against the company. Investors who acquired securities from February 26 through August 25, 2026, may contact the firm; the deadline to seek lead-plaintiff status is December 15, 2026.

Analysis

This is a procedural and headline-risk item, not evidence that the allegations are true or that D-Wave’s operating outlook has changed. The article provides no alleged misstatement, underlying event, or company response, so the case’s merits and potential financial exposure cannot be assessed from this notice. Near term, the main mechanism is likely sentiment and volatility: a high-expectations, funding-sensitive quantum-computing equity may be unusually exposed to trust shocks, but that is a conditional risk, not a demonstrated balance-sheet or revenue impact. The December 15 lead-plaintiff deadline is a procedural milestone, not a resolution of liability; more material catalysts would be the complaint’s specifics, a motion to dismiss, court rulings, or any disclosure tying the claims to operating or financial results. Do not infer company-wide misconduct or a material damages burden from a law-firm solicitation. The contrarian point is that the negative label may invite indiscriminate selling despite the absence of new substantiated information. A directional short is not supported on this notice alone.

Key Decisions for Investors

• No trade on the solicitation alone. Treat any immediate QBTS weakness as a headline-driven move unless new, verifiable allegations or company disclosures establish a link to fundamentals.
• Before changing exposure, review the filed complaint and docket for the specific alleged disclosures, relevant dates, claimed losses, and any company response; distinguish alleged facts from procedural language.
• Monitor the December 15, 2026 lead-plaintiff deadline, but do not treat it as a merits catalyst. Reassess around substantive court rulings or disclosures that could affect guidance, financing access, or investor confidence.
• Falsify the near-term overhang thesis if QBTS stabilizes and subsequent filings or company disclosures show no material operating, financial, or disclosure issue. Escalate risk if the complaint identifies specific claims contradicted by later company disclosures or if the company flags a consequential impact.